Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06631144 · ClinicalTrials.gov registry record · NA
A Spanish-language Caregiver-Enabled Care Program
A NA study of Alzheimer Disease and Dementia, sponsored by Ceresti Health.
- Active
- Registry status
- NA
- Development phase
- 270
- Enrollment target
- 1
- Study location
NCT06631144: Active NA study of Alzheimer Disease and Dementia, sponsored by Ceresti Health.
NCT06631144 is a NA study of Alzheimer Disease and Dementia that is active but no longer recruiting, run by Ceresti Health. The registered enrollment target is 270 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06631144, a NA study of Alzheimer Disease and Dementia, is active but no longer recruiting, sponsored by Ceresti Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to develop and test the feasibility of a nonmedical digital health intervention, the Spanish-language Caregiver-Enabled Care Program (CECP), with Spanish-speaking caregivers of persons with dementia (PWD). CECP is a nonmedical digital population health intervention that provides personalized education, proactive 1:1 human coaching, and remote monitoring, all delivered via a dedicated tablet shipped to the caregiver's home at no cost to the caregiver or PWD. For this study, the investigators are recruiting 135 patient/caregiver dyads.
Primary Outcome
Longitudinal Engagement for this study is assessed as the month-to-month continuation rate of Spanish-speaking caregivers enrolled in the CECP.
Conditions Studied
Interventions
- BEHAVIORAL Spanish-language Caregiver-Enabled Care Program (CECP)
Study Locations (1)
California
- Ceresti Health - Carlsbad
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2024-12-04 |
| Est. Completion | 2026-02-27 |
| Phase | NA |
What the registry record for NCT06631144 still lists
NCT06631144 is an interventional study that assigns participants to a tested intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (90% lower).
The record links to 5 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Spanish-language Caregiver-Enabled Care Program (CECP) is the first listed.
NCT06631144 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06631144 about?
NCT06631144 is a clinical study titled "A Spanish-language Caregiver-Enabled Care Program". The purpose of the study is to develop and test the feasibility of a nonmedical digital health intervention, the Spanish-language Caregiver-Enabled Care Program (CECP), with Spanish-speaking caregivers of persons with dementia (PWD). CECP is a nonmedical digital population health intervention that p...
What is the current status of trial NCT06631144?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 270 participants. The study started on 2024-12-04. Estimated completion is 2026-02-27.
What conditions does trial NCT06631144 study?
This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Caregiver Burden, Caregiver, Dementia Alzheimers.
What interventions are being tested in trial NCT06631144?
The interventions under investigation include: Spanish-language Caregiver-Enabled Care Program (CECP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06631144?
This trial is sponsored by Ceresti Health, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06631144 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06631144's enrollment target sits among peer trials
270 87th of 306 higher than 220 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- NCT04372485 · 270 participants · NA
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
- NCT04528446 · 270 participants
The Impact of Glomerular Disorders on Bone Quality and Strength
- NCT05215327 · 270 participants · Phase 2
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI